Compared with rapamycin, mammalian target of rapamycin (mTOR) dual inhibitors have shown improved ability to kill acute lymphocytic leukemia (ALL) cells in preclinical models. In this issue of Blood, Yun et al have identified novel signaling pathways downstream of mTOR that are disrupted by dual inhibitors leading to ALL cell death
Phosphatidylinositol 3-kinase (PI3K) and mammalian target of rapamycin (mTOR) are two key components...
The mammalian Target Of Rapamycin (mTOR) serine/threonine kinase belongs to two multi-protein comple...
The mechanistic target of Rapamycin (mTOR) is a ubiquitously-conserved serine/threonine kinase, whic...
Compared with rapamycin, mammalian target of rapamycin (mTOR) dual inhibitors have shown improved ab...
Acute Lymphoblastic Leukemia (ALL) is an aggressive hematologic disorder and constitutes approximate...
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase regulating cell growth, prolif...
T-cell acute lymphoblastic leukemia (T-ALL) is an aggressive blood malignancy that arises from the c...
The mammalian Target Of Rapamycin (mTOR) serine/threonine kinase belongs to two multi-protein comple...
The mammalian Target of Rapamycin (mTOR) pathway plays an essential role in sensing and integrating ...
The phosphatidylinositol 3-kinase (PI3K) and the mammalian target of rapamycin (mTOR) are two major ...
Mammalian target of rapamycin (mTOR) is an evolutionally con-served serine/threonine kinase that int...
Mammalian target of rapamycin (mTOR) is an evolutionally con-served serine/threonine kinase that int...
Over the last decade, extensive studies have been made to understand the role played by the mammalia...
The mechanistic/mammalian target of rapamycin (mTOR), a serine/threonine kinase, is a central regula...
Phosphatidylinositol 3-kinase (PI3K) and mammalian target of rapamycin (mTOR) are two key components...
The mammalian Target Of Rapamycin (mTOR) serine/threonine kinase belongs to two multi-protein comple...
The mechanistic target of Rapamycin (mTOR) is a ubiquitously-conserved serine/threonine kinase, whic...
Compared with rapamycin, mammalian target of rapamycin (mTOR) dual inhibitors have shown improved ab...
Acute Lymphoblastic Leukemia (ALL) is an aggressive hematologic disorder and constitutes approximate...
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase regulating cell growth, prolif...
T-cell acute lymphoblastic leukemia (T-ALL) is an aggressive blood malignancy that arises from the c...
The mammalian Target Of Rapamycin (mTOR) serine/threonine kinase belongs to two multi-protein comple...
The mammalian Target of Rapamycin (mTOR) pathway plays an essential role in sensing and integrating ...
The phosphatidylinositol 3-kinase (PI3K) and the mammalian target of rapamycin (mTOR) are two major ...
Mammalian target of rapamycin (mTOR) is an evolutionally con-served serine/threonine kinase that int...
Mammalian target of rapamycin (mTOR) is an evolutionally con-served serine/threonine kinase that int...
Over the last decade, extensive studies have been made to understand the role played by the mammalia...
The mechanistic/mammalian target of rapamycin (mTOR), a serine/threonine kinase, is a central regula...
Phosphatidylinositol 3-kinase (PI3K) and mammalian target of rapamycin (mTOR) are two key components...
The mammalian Target Of Rapamycin (mTOR) serine/threonine kinase belongs to two multi-protein comple...
The mechanistic target of Rapamycin (mTOR) is a ubiquitously-conserved serine/threonine kinase, whic...